全文获取类型
收费全文 | 3261篇 |
免费 | 233篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 42篇 |
儿科学 | 168篇 |
妇产科学 | 45篇 |
基础医学 | 281篇 |
口腔科学 | 154篇 |
临床医学 | 210篇 |
内科学 | 853篇 |
皮肤病学 | 28篇 |
神经病学 | 233篇 |
特种医学 | 167篇 |
外科学 | 443篇 |
综合类 | 22篇 |
一般理论 | 1篇 |
预防医学 | 189篇 |
眼科学 | 56篇 |
药学 | 210篇 |
中国医学 | 12篇 |
肿瘤学 | 397篇 |
出版年
2023年 | 11篇 |
2022年 | 30篇 |
2021年 | 85篇 |
2020年 | 32篇 |
2019年 | 79篇 |
2018年 | 105篇 |
2017年 | 57篇 |
2016年 | 75篇 |
2015年 | 106篇 |
2014年 | 103篇 |
2013年 | 154篇 |
2012年 | 190篇 |
2011年 | 202篇 |
2010年 | 134篇 |
2009年 | 96篇 |
2008年 | 151篇 |
2007年 | 145篇 |
2006年 | 152篇 |
2005年 | 171篇 |
2004年 | 121篇 |
2003年 | 135篇 |
2002年 | 159篇 |
2001年 | 99篇 |
2000年 | 147篇 |
1999年 | 95篇 |
1998年 | 50篇 |
1997年 | 36篇 |
1996年 | 38篇 |
1995年 | 30篇 |
1994年 | 40篇 |
1993年 | 21篇 |
1992年 | 53篇 |
1991年 | 50篇 |
1990年 | 59篇 |
1989年 | 45篇 |
1988年 | 36篇 |
1987年 | 27篇 |
1986年 | 25篇 |
1985年 | 24篇 |
1984年 | 19篇 |
1983年 | 14篇 |
1982年 | 6篇 |
1981年 | 11篇 |
1980年 | 10篇 |
1979年 | 11篇 |
1978年 | 7篇 |
1977年 | 11篇 |
1976年 | 7篇 |
1975年 | 9篇 |
1973年 | 6篇 |
排序方式: 共有3511条查询结果,搜索用时 15 毫秒
1.
María Cabrerizo Gloria Trallero María José Pena Amaia Cilla Gregoria Megias Carmen Mu?oz-Almagro Eva Del Amo Diana Roda Ana Isabel Mensalvas Antonio Moreno-Docón Juan García-Costa Nuria Rabella Manuel Ome?aca María Pilar Romero Sara Sanbonmatsu-Gámez Mercedes Pérez-Ruiz María José Santos-Mu?oz Cristina Calvo And the study group of “Enterovirus parechovirus infections in children under ?years-old Spain” PI- 《European journal of pediatrics》2015,174(11):1511-1516
2.
The use of decision analysis in selecting a histamine H2-receptor antagonist for the formulary at a hospital in Spain is described. Cimetidine, ranitidine, and famotidine were identified as the possible alternatives. The evaluation criteria established were therapeutic efficacy, adverse effects, drug interactions, years of clinical use, dosage interval, cost, and dosage forms. The relative importance of the criteria was determined by assigning utility values to each. Probability values were assigned to estimate how well each drug met each criterion. By multiplying the utility and probability values for each criterion and summing the scores, a total score was calculated for each drug. The alternative with the highest total score was ranitidine. A sensitivity analysis showed that the results were stable over a plausible range of probability and utility values. Accordingly, ranitidine was selected for inclusion on the formulary. Decision analysis provided an effective method for selecting which histamine H2-receptor antagonist to include on the hospital's formulary. 相似文献
3.
4.
5.
Felipe A. Calvo David Ortiz de Urbina Luis Sierrasesúmaga Oscar Abuchaibe Ignacio Azinovic Federico Antillon Manuel Santos Jos Canadell 《Pediatric blood & cancer》1991,19(6):478-485
From September 1984 to December 1989, 38 patients of pediatric age with localized bone sarcomas received intraoperative radiotherapy (IORT) as part of a multidisci plinary treatment program. The age ranged from 6 to 21 years. The tumor histologies were 22 osteosarcomas and 16 Ewing's sarcomas. Thirty-four had initial primary disease (90%) and 4 were treated for local recurrence (10%). IORT was used on 32 untreated patients and in 6 previously treated with external beam radiotherapy (EBR). The IORT field included the surgically exposed tumor bed area. Single radiation doses ranging from 10 to 20 Gy were delivered, using 6–20 MeV electron beams. The median follow-up time for the entire group is 25 months (2–65+ months). The projected 5-year disease-free and overall survival rates are 65% and 69%, respectively. One patient developed a local recurrence in each histological group: one chondroblastic osteosarcoma and one cervical Ewing's sarcoma. Six patients died from metastatic progression: 3 initially recurrent tumors and three primary disease cases. Severe neuropathy and soft tissue necrosis were seen in some patients as IORT related complications. IORT is a feasible technique to be integrated in multidisciplinary programs that may promote local control in pediatric and adolescent patients with bone sarcomas. Peripheral nerves are dose-limiting tissue structures for IORT. 相似文献
6.
J. A. Garrote A. Blanco M. Alonso E. Arranz C. Calvo 《Pediatric allergy and immunology》1991,2(4):199-204
The new diagnostic criteria of coeliac disease (CD) give more importance to serological markers. Immunoglobulin A antiendomysial antibodies (IgA-EmA) were determined in 138 sera from 79 coeliac children and the antibody levels compared to IgG and IgA antigliadin antibodies (IgG-AGA, IgA-AGA) in the sera. The assessment was also carried out in 29 children with other gastrointestinal diseases, 29 with non-gastrointestinal diseases and 35 healthy children. The IgA-EmA had a 91.4% specificity and a 88.4% sensitivity for active CD. The corresponding figures were 89.8% and 64.4% for IgA-AGA and 73.7% and 86.2% for IgG-AGA, respectively. The results of IgA-EmA determinations were concordant with the intestinal biopsy findings in 90% of cases, versus 80% for IgA-AGA and 83% for IgG-AGA. In most of the discordant cases the biopsy showed only minor changes, making the classification difficult. All patients with positive IgA2 -EmA also had positive IgA1 EmA antibodies. IgA-EmA are an excellent serological marker of CD activity in children and they are useful to decrease the number of intestinal biopsies which are needed to confirm the diagnosis in coeliac patients. 相似文献
7.
8.
F. A. Calvo O. Abuchaibe I. Azinovic E. Tangco J. Aristu R. Martínez F. Pardo J. Alvarez-Cienfuegos J. M. Berián 《European radiology》1992,2(1):29-34
Thirty patients with malignant tumours in the upper abdomen underwent surgery and intraoperalive radiation (IORT), using electron beam, to: the surgical bed, residual or unresected tumour. The technical aspects and results of this treatment are described. Renal, adrenal, bile duct and gastrointestinal tumours were treated. along with several other lesions. The surgical procedure consisted in 10 cases simply of exposure of the tumour for IORT and in 20 the tumour was resected. The TORT dose ranged from 10 to: 20 Gv. In 13 patients, external beam radiation was also given to: residual tumour or to: areas of high risk for recurrence. Chemotherapy was given to: 10 patients. Tolerance to: the combined treatment was acceptable; with few complications related to: IORT.The median follow-up and survival time 23 months (range 4-more than 70 months). Local tumour control rate (or tumour stabilisation) is 90%. Distant metastases developed in 19 patients (63%). The actuarial survival rate for the group projected at 70 months (maximum follow-up) is 37%. IORT in useful in the management of tumours arising in the upper abdominal organs, for palliation surgery or when resectability of the tumour is in doubt. Indications for IORT include patients with uncommon tumours of the upper abdomen who are not be candidates for standardised cancer treatment.Presented at the European Congress of Radiology, Vienna, September 15–20,1991 相似文献
9.
10.
J C Marvizón J Vázquez M García Calvo F Mayor A Ruíz Gómez F Valdivieso J Benavides 《Molecular pharmacology》1986,30(6):590-597
The displacement by glycine of 3H-strychnine binding to rat spinal cord membranes cannot be explained by a simple competitive interaction. Indeed, protein-modifying reagents can completely abolish the inhibition of 3H-strychnine binding by glycine and other agonists, whereas the interaction of strychnine itself and other related compounds with the binding site is unimpaired. Moreover, glycine cannot inhibit completely saturable 3H-strychnine binding, the extent of its maximum inhibitory effect depending on the ionic composition of the medium. Hill coefficients less than 1 (whose magnitude also depends on the assay medium) were obtained from glycine displacement curves. These properties are consistent with a mathematical model of two different, but mutually interacting, binding sites for strychnine and glycine on the glycine receptor. The effect of ions and protein-modifying reagents might be explained in this model as modifications of the mechanisms that mediate the allosteric interaction, and/or the affinity of glycine for the receptor. The agonists beta-alanine and taurine and the new antagonists, THAZ, iso-THAZ, and 4,5-TAZA, also seem to interact with a site different from the strychnine-binding site, probably the glycine-binding site. 相似文献